• From Point of Care to the Bottom Line--How Ambient AI Strengthens Revenue Integrity
    Nov 18 2026

    In this episode, Mike Valli, Chief Revenue Officer and Chief Value Officer at Ambience Healthcare discusses "From Point of Care to the Bottom Line: How Ambient AI Strengthens Revenue Integrity."

    Show More Show Less
    14 mins
  • The CFO’s Role in Healthcare AI--Cost, Value and Governance
    Nov 11 2026

    In this episode, Alina Henderson, Vice President of Healthcare Solutions at Strata Decision Technology discusses the CFO's role in healthcare AI: cost, value, and governance.

    Show More Show Less
    23 mins
  • When a Hospital Closes-Nobody Wins
    Nov 4 2026

    In this episode, Dr. Wael Khouli, Physician Executive and former Chief Medical officer and Gretchen Heinen, CEO and Founder of Authsnap, Inc. discusses "When a hospital closes, nobody wins."

    Show More Show Less
    19 mins
  • Reshaping Revenue Cycle Strategy for Healthcare’s Next Era
    Oct 28 2026

    In this episode, Scott Schrader Head - Healthcare Provider at Firstsource discusses reshaping revenue cycle strategy for healthcare's next era.

    Show More Show Less
    15 mins
  • The Margin Hospitals Already Earned, But Never See
    Oct 21 2026

    In this episode, Venkat Mocherla, Co-Founder and President of Midstream Health discusses the margin hospitals already earned but never see.

    Show More Show Less
    19 mins
  • From CFO to Cancer Research–A Conversation About Challenging Assumptions [PODCAST]
    Oct 14 2026
    ← Back to All Podcasts From CFO to Cancer Research — A Conversation About Challenging Assumptions In this episode, Ted Giovanis, President of the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, discusses from CFO to cancer research, a conversation about challenging assumptions. Highlights of this episode include: What drives hospital CFOs to keep taking on entirely new challengesOne thing about how healthcare operates today that we should fundamentally rethinkA question about healthcare we’re still not askingReturn on investment when it comes to scientific research that may take years to pay offWhich is more expensive for healthcare, trying something new that might fail or continuing to do things the way we’ve always done them?What lessons to apply for improving healthcare and cancer research Subscribe Today! Kelly Wisness: Hi, this is Kelly Wisness. Welcome back to the award-winning Hospital Finance Podcast. We’re pleased to welcome Ted Giovanis. Ted has been the president of the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, which conducts research in metastatic breast cancer and health policy. He is also a professional race driver and team owner in the International Motorsports Association Racing Series. Examples of health policy research that their foundation has conducted include research on the value of hospital tax exemptions relative to hospital-provided charity free care, how to explain health plan prices and quality information to individuals with varying degrees of numeracy and literacy, and defining meaningful quality measures, including the weighting of those measures into aggregate measures for communication to patients. While in practice, Ted was involved in several legislative efforts that resulted in the establishment and implementation of several payment mechanisms, including the Medicare Geographic Review Board and Section 508 reclassification process, the policy for the payment of the certified registered nurse anesthetists, and the long-term care payment systems for various states. Most notably, Ted discovered and prosecuted the Medicare budget neutrality error, which was the basis of the rural floor budget neutrality appeal and related settlements that at the time was the largest settlement Medicare had lost. In this episode, we’re discussing from CFO to cancer research, a conversation about challenging assumptions. Welcome, and thank you for joining us, Ted. Ted Giovanis: Oh, thanks, Kelly. Thanks. Good to be here. Kelly: So, let’s go ahead and jump in. So, you’ve been a hospital CFO. You’ve helped shape healthcare policy, been part of a landmark court case, written books, and now race professionally and fund cancer research. What drives you to keep taking on entirely new challenges? Ted: Well, that’s a really good question. So, I can tell you as far back as I can remember, I’ve had this drive to achieve. Maybe it was the fact I was an only child, and we didn’t have any money. But to achieve, you need to be very goal-oriented. And in this sense, I’m the typical Capricorn. I set goals and I locomote towards them. I started in healthcare and finance and worked my way up, setting goals all the way along the line. And somewhere around 1978, I became acquainted with a guy named Mike Vance, who was an influential thought leader and author. And he was the one that instilled in me a commitment to a lifetime of continuous learning and growth. And ever since then, that’s sort of what I’ve been doing. That curiosity has led me to ask a lot of questions that others wouldn’t ask, which brought me to the lawsuit, ironically, and has also led me to cancer research. So, asking questions prompts you to try to find the answers. And if you don’t know the answers, you talk to other people and you try to find them from them. So, you look up to people that can give you the answers. So as a bonus, as it turns out, as you age, learning more and staying mentally active is a big plus. A long time ago, Henry Ford once said, “Anyone who stops growing is old, whether that happens at 20 or 80.” I just turned 80, and I don’t plan on stopping anytime soon. And Henry Ford also said, “Anyone who keeps growing becomes more valuable, regardless of physical capacity.” So, I hope I’m becoming and learning and growing and becoming more valuable. Kelly: Yeah, I love that committing to a lifetime of learning and growth. That is great advice. After decades in healthcare finance, what’s one thing about how healthcare operates today that you think we should fundamentally rethink? Ted: Well, I think there’s one thing we need to rethink. It’s actually how to lead there’s a lot of people in healthcare today that are talking about being patient-centered, patient-centric, but too often they don’t think patient-centric in the way they make decisions. So, we need leaders willing to challenge the status quo. And...
    Show More Show Less
    15 mins
  • Revenue Recovery That Pays for Itself--Fixing Hidden Leaks
    Oct 7 2026

    In this episode, Beverly Neal-Clinton, Marine and Co-Founder of servehealrecover.com discusses revenue recovery that pays for itself by fixing hidden leaks.

    Show More Show Less
    17 mins
  • Locking Down Corporate AI Usage Webinar
    Oct 2 2026
    ← Back to All Podcasts Locking Down Corporate AI Usage Webinar In this episode, Jason Nadal, Besler Holdings’ and Sypher Security’s Information Security Officer, will provide us with a glimpse into the next Hospital Finance Academy Webinar, “Locking Down Corporate AI Usage,” live on Wednesday, October 7th, at 1 PM ET. Highlights of this episode include: How companies deal with artificial intelligence and how they should make the decision to embrace this technologyWhat the benefits and detriments of AI usage are What tools out there to help protect your company and your dataWhat other challenges you have in keeping aware of AI usageHow you manage third parties not directly under your controlThe key takeaways Subscribe Today! Kelly Wisness: Hi, this is Kelly Wisness. Welcome back to the award-winning Hospital Finance Podcast. We’re pleased to welcome back Jason Nadal, Besler Holdings’ and Sypher Security’s Information Security Officer. In this episode, Jason will provide us with a glimpse into our next Hospital Finance Academy Webinar, “Locking Down Corporate AI Usage,” live on Wednesday, October 7th, at 1 PM Eastern Time. Welcome back, and thank you for joining us, Jason. Jason Nadal: Hi. Thanks for having me. Kelly: All right. Well, let’s go ahead and jump in. So, we know artificial intelligence is everywhere now. How should companies deal with this and make the decision to embrace this technology? Jason: Well, if you run a company right now, somebody on your team is likely already using AI. So ideally, that would be via an approved path that you have already set up, but maybe it’s just a browser tab they opened up at lunch, putting something in Google and getting AI results. Either way, the question is not, “Should we use AI?” It’s already embedded in a lot of the approved corporate tools that are already out there. So, the question is, “Do we know what we allow, what we forbid, and how do we keep that promise when the tools keep changing under our feet?” So those are the kinds of conversations that security and IT folks have when leadership asks for a practical plan around AI. So, over the next 10 minutes or so, I’ll walk through some of the benefits and risks. We’ll get into that a bit deeper during the webinar that’s upcoming, but this will give you a methodology of control you can actually run, some of the categories of tooling that support it, and the challenge of feature creep in tools that you’ve already approved. And we’re also going to look at how a vendor and open-source software assessment has to catch up. Kelly: Yeah. I mean, it is really everywhere. It’s embedded in everything now, it seems like. [laughter] Yeah. It’s a lot to keep up with. So, what are the benefits and detriments of AI usage? Jason: Sure. There’s a lot of benefits, and there’s definitely a lot of detriments as well. So, AI earns its value when it shortens the work that you’re already doing, especially that work that used to waste a lot of your time through just tedium, repeated tasks, and things like that. So, I find it really shines at drafting, summarizing, searching or researching, coding assists, and also triaging helpdesk tickets. So those are real-time gains when the data and the use case match the risk. So, in healthcare and adjacent work, that might be a little less clear. So, a nurse or revenue cycle analyst can summarize a long chart note, draft a patient letter, or speed up some prior auth paperwork. A cost report or appeals team can find patterns faster. So done carefully, ideally with this human oversight as to what’s produced, that is time returned to care and to accurate billing. But the downside is just as concrete. So, paste the wrong note into a public chatbot, and you may have moved protected health information, PHI, or something else confidential or sensitive, outside your control. So, a helpful summarizer can invent a fact, called hallucinations, that then gets treated like clinical or financial truth. There’s really a huge downside to that if it’s not checked over by humans with clinical experience. An automation that writes into scheduling, ticketing, or an EHR-adjacent system can turn a bad model answer into a real patient or operations problem. Outside of healthcare, the pattern is much the same. So, marketing could paste customer lists into a public model. Finance could paste financial forecasts. Engineering could paste source code or API keys, maybe in a hurry or just this one time, and leak information that you don’t really intend to leak. Legal can paste contract language. You get the benefit of speed, but the detriment of leaking your data, over trusting the AI, and a trail that, once it’s out there, you can’t really tidy it up after the fact. So, a key point to establishing governance is having frank discussions of what data is acceptable to this risk if it were to leak. I really can’t say...
    Show More Show Less
    19 mins